Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SEDANA.STthis companySedana Medical AB (publ)	SEK 9.64	-17.13×	1.13×	5.1×	-92.41×	-488.3%	71.3%	-16.1%	-29.6%	-6.6%	-3.5%	-7.4%	0.01×	8.53×	-22.12×	3.4×	0.0%	2	10.28	2	C+
BICO.STBICO Group AB (publ)	SEK 23.75	-1.36×	0.85×	0.99×	-48.97×	-130.1%	38.9%	-16.8%	-72.7%	-62.3%	-7.9%	3.7%	0.86×	-6.38×	-0.78×	1.27×	0.0%	6	-2.84	3	B-
CRAD-B.STC-Rad AB (publ)	SEK 23.60	103.06×	3.12×	2.45×	16.63×	-54.3%	69.2%	10.2%	2.4%	3.0%	8.3%	4.6%	0.03×	-2.92×	49.18×	3.09×	0.0%	4	5.23	4	A-
DMYD-B.STDiamyd Medical AB (publ)	SEK 0.98	-0.58×	0.61×	310.44×	0.62×	98.3%	-478.8%	-54562.9%	-53583.4%	-104.9%	-78.6%	-132.6%	0×	1.21×	-73.88×	9.08×	0.0%	3	-0.68	2	B-
GENO.STGenovis AB	SEK 21.00	59.03×	5.15×	10.84×	34.56×	-59.9%	21.3%	21.3%	18.2%	8.7%	6.8%	2.2%	0.52×	-0.59×	7.29×	7.36×	0.0%	4	8.04	3	B-
ONCO.STOncopeptides AB (publ)	SEK 1.82	-4.37×	-18.53×	15.35×	-5.24×	-767.7%	83.0%	-317.6%	-350.9%	423.8%	-230.4%	-20.4%	-2.37×	-0.26×	-15.63×	2.63×	0.0%	3	0.46	1	D+
Peer median	—	-0.58×	0.85×	10.84×	0.62×	-59.9%	38.9%	-16.8%	-72.7%	3.0%	-7.9%	2.2%	0.03×	-0.59×	-0.78×	3.09×	0.0%	4	0.46	3	—